FineMark National Bank & Trust - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 152 filers reported holding WUXI PHARMATECH CAYMAN INC in Q3 2015. The put-call ratio across all filers is 2.14 and the average weighting 0.7%.

Quarter-by-quarter ownership
FineMark National Bank & Trust ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q3 2015$41,000
+2.5%
9570.0%0.01%
+20.0%
Q2 2015$40,000
+8.1%
9570.0%0.01%0.0%
Q1 2015$37,000
+105.6%
957
+79.2%
0.01%
+66.7%
Q4 2014$18,000
-5.3%
5340.0%0.00%0.0%
Q3 2014$19,000
+5.6%
5340.0%0.00%0.0%
Q2 2014$18,000
-10.0%
5340.0%0.00%
-25.0%
Q1 2014$20,0000.0%5340.0%0.00%0.0%
Q4 2013$20,0005340.00%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q3 2015
NameSharesValueWeighting ↓
PSquared Asset Management AG 171,495$7,410,00032.67%
Newport Asia LLC 714,600$30,877,00012.95%
Coupland Cardiff Asset Management LLP 45,000$1,944,0006.29%
NINE MASTS CAPITAL Ltd 525,985$22,730,0005.83%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 2,694,589$116,433,0005.17%
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC 220,131$9,512,0004.79%
Sensato Investors LLC 549,341$23,737,0004.44%
Grandeur Peak Global Advisors, LLC 396,743$17,143,0003.83%
Taconic Capital Advisors LP 2,150,000$92,902,0003.43%
Central Asset Investments & Management Holdings (HK) Ltd 68,815$2,973,0003.26%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders